Drug Shortage Report for TEGRETOL SUSPENSION
Report ID | 64629 |
Drug Identification Number | 02194333 |
Brand name | TEGRETOL - SUS 100MG/5ML |
Common or Proper name | TEGRETOL SUSP 100MG/5ML 450ML |
Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | CARBAMAZEPINE |
Strength(s) | 100MG |
Dosage form(s) | SUSPENSION |
Route of administration | ORAL |
Packaging size | 450 ML |
ATC code | N03AF |
ATC description | ANTIEPILEPTICS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2018-10-19 |
Actual start date | 2018-10-19 |
Estimated end date | 2019-12-11 |
Actual end date | 2018-12-17 |
Shortage status | Resolved |
Updated date | 2018-12-18 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
Company contact information | customer.relations@novartis.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2018-10-17 | English | Compare |
v2 | 2018-10-17 | French | Compare |
v3 | 2018-10-20 | English | Compare |
v4 | 2018-11-01 | English | Compare |
v5 | 2018-11-01 | French | Compare |
v6 | 2018-11-01 | English | Compare |
v7 | 2018-11-16 | English | Compare |
v8 | 2018-11-16 | French | Compare |
v9 | 2018-12-18 | English | Compare |
v10 | 2018-12-18 | French | Compare |
Showing 1 to 10 of 10